novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Heart Failure 2016 & 3RD WORLD CONGRESS ON ACUTE HEART FAILURE

16 Fevereiro 2016

Heart Failure Congress 2016

Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

16 Fevereiro 2016
0

Benign and pathological electrocardiographic changes in athletes

16 Fevereiro 2016
0